Androgenic Alopecia Therapeutics - Pipeline Analysis GSK, Almirall, Allergan, RepliCel Life Sciences Inc.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/androgenic-alopecia-therapeutics-pipeline-analysis/report-sample
Androgenic alopecia is a genetic disorder that affects both men and women and is characterized by hair loss in both the sexes. Androgenic alopecia is also known as male-pattern baldness in men and female-pattern baldness in women. The predisposing factors for androgenic alopecia include allergies, burns, irritants, injuries, infections, and toxins.
*Various Collaborations for Androgenic Alopecia Therapeutics Drug Development
In August 2017, Aclaris Therapeutics, Inc. acquired Confluence Life Sciences, Inc., a privately held biotechnology company for a consideration of $10 million in cash and issued approximately 350,000 shares of its common stock, with a value of approximately $10 million on the closing date to expand the dermatological pipeline of Aclaris Therapeutics, Inc.
Browse report at: https://www.psmarketresearch.com/market-analysis/androgenic-alopecia-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of androgenic alopecia therapeutics include GlaxoSmithKline plc, Almirall S.A., Allergan plc, RepliCel Life Sciences Inc. and others.
*Positive Clinical Results of Androgenic Alopecia Therapeutics Candidates
The positive clinical results of androgenic alopecia drug candidates have been driving the pipeline growth. Many drug candidates have shown positive clinical results and are proceeding further towards development. In February 2016, Cassiopea S.p.A. reported the top-line results from the proof of concept, Phase II clinical trial of Breezula (CB-03-01), in androgenic alopecia and it was found that Breezula, met both its two pre-defined co-primary efficacy endpoints, increase in total area hair count within 1 cm2 (TAHC) and subject hair growth assessment (HGA) at six months. Breezula also demonstrated favorable safety profile.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=androgenic-alopecia-therapeutics-pipeline-analysis
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Androgenic Alopecia Therapeutics - Pipeline Analysis GSK, Almirall, Allergan, RepliCel Life Sciences Inc. here
News-ID: 1414153 • Views: 2407
More Releases from P&S Intelligence
APAC Is Dominating Forklift Market
The forklift market is experiencing growth and is projected to reach USD 42,519.4 million by the end of this decade, as per P&S Intelligence. This growth can be credited to the thriving e-commerce industry and the launch of new and better autonomous and electric forklifts. To download free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/forklift-market/report-sample Class 2 forklifts are narrow-aisle models, including order pickers, electric stand-up riders, reach trucks, and side loaders. Such
Data Center UPS Market Will Reach USD 10,096.5 Million by 2030
In 2022, the data center UPS market was worth around USD 5,729.0 million, and it is projected to advance at a 6.5% CAGR from 2022 to 2030, hitting USD 10,096.5 million by 2030, according to P&S Intelligence. The growth can be ascribed to the formation of new data centers, as the need for data storage is strongly growing among all the sectors worldwide, mainly to offer big data solutions. Mainly because
Thailand DG Set Market To Reach USD 236.9 Million in 2030
The total size of the Thailand DG set market was USD 158.3 million in 2021, and it will reach a value of USD 236.9 million in 2030, progressing at a rate of 4.6% in the years to come, as stated by a market research company, P&S Intelligence. The commercial sector dominated the industry, with over 40% share, and it will grow at a rate of approximately 5% in the years to
Mobile Video Surveillance Market To Touch USD 4,337 Million by 2030
The size of the mobile video surveillance market was USD 2,250 million in 2022, and it will power at a rate of 8.6% in the years to come, to touch USD 4,337 million by 2030. On the basis of offering, hardware had a major share, of 42%, credited to the progressions in cameras, for example improved recording quality in low light, cohesive motion sensors for object tracking, encryption of data and
More Releases for Androgenic
Insights on the Androgenic Alopecia Drug Market to 2027 | Industry Statistics, E …
The global androgenic alopecia drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The growing prevalence of hair loss, technological advancements in alopecia treatment, and the rise in prevalence of chronic diseases that are associated with hair loss are some of the major factors driving the market. According to data published by the American Hair Loss Association, it was stated that over 95.0% of
(2020-2026) Androgenic Alopecia Therapeutics MARKET GROWTH, EMERGING TRENDS, TOP …
QY Research offers its latest report on the Global Androgenic Alopecia Therapeutics Market Size, Status and Forecast 2020-2026 that includes comprehensive analysis on a range of subjects such as competition, segmentation, regional expansion, and market dynamics. Some of the Major key players operating in this Report are: Johnson & Johnson, Merck, GlaxoSmithKline, Astellas Pharma, Cipla, Almirall, Sun Pharma, Reddy's Laboratories, Concert Pharmaceuticals, RiverTown Therapeutics, Brickell Biotech, BiologicsMD, Aclaris Therapeutics The report has
Androgenic Alopecia Therapeutics Pipeline Analysis Report -Clinical Trials & Res …
The study analyzed that the androgenic alopecia therapeutics pipeline comprises approximately 24 active drug candidates in different stages of development. Androgenic alopecia is a genetic disorder that affects both men and women and is characterized by hair loss in both the sexes. Androgenic alopecia is also known as male-pattern baldness in men and female-pattern baldness in women. The predisposing factors for androgenic alopecia include allergies, burns, irritants, injuries, infections, and
Global Androgenic Alopecia Drug Market Trends, Sales, Industry Analysis and Dema …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Androgenic Alopecia Drug Market Research Report (2018-2025)” which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% by the end of 2025. The report also studies the Androgenic Alopecia Drug market worldwide, especially in North America, China, Europe, Southeast
Androgenic Alopecia Therapeutics Pipeline Analysis - Clinical Trials & Results, …
Androgenic Alopecia is a genetic disorder characterized by the hair loss in both men and women. The disease occurs when terminal hair is gradually converted into indeterminate, and finally into vellus, hair. The predisposing factors for androgenic alopecia include allergies, burns, irritants, injuries, infections and toxins. Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/androgenic-alopecia-therapeutics-pipeline-analysis Androgenetic alopecia in men has been associated with several other medical conditions including enlargement of the prostate
Global Androgenic Alopecia Clinical Trials Industry Review :H1-2017 | Diseases M …
Market Research Hub's clinical trial report, Global Androgenic Alopecia Clinical Trials Review, H1, 2017, provides an overview of Androgenic Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on Androgenic Alopecia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Request Free Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068385 The report offers coverage of disease clinical trials by region, country (G7